It is suggested that the platforms could influence patients in favour of the pharma giants or lead to inappropriate ...

The company is suing some online vendors and medical spas for selling copycats of a weight loss and diabetes drug.

Though Lilly has been in the spotlight for the success of its GLP-1 drugs, the pharma giant has also been investing in a corporate brand campaign to boost its overall reputation.

A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for ...

Michigan's Supreme Court reexamines rulings that may affect how the state's consumer protection laws apply to insulin pricing ...

Eli Lilly is expanding its innovation digs to Beijing, opening two research centers called the Eli Lilly China Medical ...

Nessel’s office must petition the court with a formal petition for investigative subpoenas. Those were filed in January 2022 and challenged by Eli Lilly, launching the nearly two-year court ...

Weaver Capital Management LLC lessened its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.0% in the 3rd quarter ...

Industry leaders Novo Nordisk (NVO) and Eli Lilly (LLY) are already struggling to meet soaring demand, facing significant shortages of their weight loss and diabetes medications. Now, these ...

Two years after Michigan Attorney General Dana Nessel filed an application to appeal an order preventing her department from ...

Elevated Capital Advisors LLC lifted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 20.8% in the ...

Lots of money is pouring into two critical races for Washington's legislature this year — and some big name companies are ...